自动定量瞳孔测量在危重症患者中的应用:系统综述
该系统综述检索了1990至2019年三个数据库,纳入58篇使用手持自动瞳孔测量设备研究成人危重症患者的文章,共3246例患者。证据等级多为2至3级,最高等级证据涉及疼痛、阿片类药物使用及颅内压升高的潜在混杂效应。结论认为瞳孔光反射易受合并症和治疗方案影响,这些混杂因素可能导致治疗过度或不足。
要点
- 疼痛、阿片类药物使用和颅内压升高是瞳孔光反射预测结局的主要混杂因素。
- 其他潜在混杂因素包括SSRI、α2肾上腺素受体激动剂和NMDA拮抗剂。
- 使用瞳孔指标指导治疗时需警惕混杂因素导致的过度或不足治疗风险。
核心结论
- 瞳孔光反射易受合并症和治疗方案影响,疼痛、阿片类药物使用和颅内压升高对结局和瞳孔反射有潜在混杂效应。
- 当治疗由瞳孔指标指导时,这些混杂因素使患者面临过度治疗或治疗不足的风险。
研究设计与样本
- 系统检索PubMed、EmBase和Cochrane三个数据库,纳入1990至2019年使用单眼自动手持设备研究成人危重症患者的文章。
- 共纳入58篇符合条件的文章,涉及3246例患者,包括病例报告、原创研究和系统综述。
- 使用牛津循证医学中心分类对研究进行证据分级,最高等级证据来自10项随机试验和19项前瞻性观察性研究。
主要发现
- 证据等级大多为2至3级,最高等级证据涉及疼痛、阿片类药物使用和颅内压升高的潜在混杂效应。
- 还发现了其他潜在混杂因素:选择性5-羟色胺再摄取抑制剂、α2肾上腺素受体激动剂和NMDA拮抗剂。
临床怎么用
- 在危重症患者中使用自动瞳孔测量预测结局时,需考虑疼痛、阿片类药物和颅内压升高等混杂因素。
- 基于瞳孔指标指导治疗时,应警惕混杂因素可能导致过度治疗或治疗不足。
局限性
- 证据等级多为2至3级,部分研究证据等级较低。
- 综述提示可能还存在更多未探索的混杂因素,未来研究需验证和识别更多混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A systematic literature search has been performed to identify potential confounders for outcome prediction using pupillary light reflex in adult critically ill patients, as measured by handheld automated pupillometry devices. METHODS: Three digital databases (PubMed, EmBase, Cochrane) were systematically searched. Articles published between 1990 and 2019 in adult patients using monocular automated handheld devices were considered. Studies were classified according to the Oxford Centre for Evidence-Based Medicine classification (level 1 represents the highest and level 5 the lowest level of evidence). Case reports, original research, and systematic reviews were included and cross-referenced. RESULTS: With the use of 202 search terms, 58 eligible articles reporting the use of handheld pupillometry in the critically ill could be identified, considering 3,246 patients. The highest level of evidence came from 10 randomized trials and 19 prospective observational studies. The level of evidence was mostly 2 to 3 and highest with studies regarding the potential confounding effects of pain, the use of opioids, and increased intracranial pressure. Additional potential confounders found are selective serotonin reuptake inhibitors, α2-adregenic receptor agonists, and NMDA antagonists. CONCLUSIONS: The pupillary light reflex is susceptible to factors resulting from underlying comorbid conditions and effects of treatment regimens. Scenarios frequently encountered in critical care such as pain, use of opioids, and proof of increased intracranial pressure have potential confounding effects on outcome and pupillary reflexes. When treatment is guided by pupillary metrics, such confounders put patients at risk of overtreatment or undertreatment. Future research should validate and identify additional confounders, because our review suggests that even more unexplored confounders may exist.
引用
- Opic P, Rüegg S, Marsch S, et al. Automated Quantitative Pupillometry in the Critically Ill: A Systematic Review of the Literature. Neurology. 2021. PMID: 34045270. doi:10.1212/WNL.0000000000012295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。